Intervention | RE informative analysis | RE vague analysis | FE analysis | |||
RR (95% CrI) | SUCRA |
RR (95% CrI) | SUCRA |
RR (95% CrI) | SUCRA | |
Treatment efficacy | ||||||
Control (reference trt) | 1 | 0.06 | 1 | 0.08 | 1 | 0.03 |
INH 3–4 | 0.81 (0.28–2.23) | 0.17 | 0.80 (0.18–3.29) | 0.20 | 0.82 (0.61–1.09) | 0.15 |
INH-6 | 0.41 (0.19–0.80) | 0.52 | 0.40 (0.14–1.00) | 0.50 | 0.42 (0.32–0.55) | 0.56 |
INH-9 | 0.49 (0.07–1.59) | 0.46 | 0.36 (0.03–1.67) | 0.56 | 0.62 (0.26–1.46) | 0.31 |
INH12–72 | 0.24 (0.11–0.46) | 0.89 | 0.22 (0.08–0.54) | 0.84 | 0.24 (0.17–0.34) | 0.97 |
INH/RPT-3 | 0.35 (0.10–0.88) | 0.67 | 0.31 (0.07–1.11) | 0.65 | 0.37 (0.21–0.61) | 0.68 |
INH/RFMP 3–4 | 0.49 (0.19–0.99) | 0.42 | 0.45 (0.13–1.18) | 0.44 | 0.52 (0.36–0.75) | 0.38 |
RFMP/PZA-2 | 0.31 (0.10–0.78) | 0.72 | 0.29 (0.06–1.01) | 0.68 | 0.32 (0.19–0.52) | 0.79 |
INH/RFMP/PZA-3 | 0.38 (0.15–0.86) | 0.59 | 0.36 (0.11–1.12) | 0.56 | 0.39 (0.24–0.61) | 0.63 |
Resdev; # DP | 41.92; 38 | 38.0; 38 | 57.3; 38 | |||
DIC | 203.88 | 200.9 | 213.2 | |||
SD | 0.44 (0.02–1.06) | 0.66 (0.25–1.49) | NA | |||
Treatment completion | ||||||
Intervention | OR (95% CrI) | SUCRA | OR (95% CrI) | SUCRA | OR (95% CrI) | SUCRA |
Placebo-12 (reference trt) | 1 | 0.06 | 1 | 0.14 | 1 | 0.08 |
Placebo-3 | 4.17 (1.96–8.60) | 0.88 | 4.15 (1.64–10.45) | 0.76 | 4.44 (3.78–5.23) | 0.88 |
INH-3/4 | 3.01 (1.39–6.42) | 0.68 | 3.01 (1.15–7.94) | 0.68 | 3.01 (2.68–3.36) | 0.68 |
INH/RPT-3 | 3.58 (1.40–8.83) | 0.79 | 3.54 (1.17–10.44) | 0.84 | 3.87 (2.56–5.80) | 0.95 |
RFMP/PZA-2 | 2.44 (1.11–5.36) | 0.54 | 2.45 (0.94–6.50) | 0.58 | 2.28 (1.87–2.77) | 0.44 |
INH/RFMP/PZA-3 | 2.36 (1.02–5.40) | 0.52 | 2.35 (0.85–6.64) | 0.54 | 2.41 (1.79–3.26) | 0.48 |
INH/RFMP 3–4 | 3.14 (1.43–6.77) | 0.72 | 3.12 (1.22–8.13) | 0.78 | 3.20 (2.44–4.24) | 0.79 |
RFMP 3–4 | 3.95 (1.15–13.72) | 0.81 | 3.95 (0.93–17.45) | 0.79 | 4.14 (2.49–6.87) | 0.89 |
Placebo-6 | 1.94 (0.95–3.88) | 0.38 | 1.93 (0.80–4.67) | 0.41 | 2.00 (1.75–2.29) | 0.30 |
INH-6 | 1.49 (0.73–2.89) | 0.22 | 1.48 (0.62–3.44) | 0.32 | 1.58 (1.42–1.75) | 0.18 |
INH-9 | 1.64 (0.57–4.45) | 0.29 | 1.61 (0.46–5.38) | 0.31 | 1.87 (1.23–2.83) | 0.43 |
INH12–72 | 1.16 (0.59–2.45) | 0.11 | 1.19 (0.52–3.03) | 0.07 | 0.97 (0.87–1.07) | 0.01 |
Resdev; # DP | 36.33; 35 | 35.22; 35 | 63.93; 35 | |||
DIC | 274.54 | 274.06 | 295.29 | |||
SD | 0.33 (0.16–0.63) | 0.41 (0.20–0.83) | NA |